Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A tumor-associated heparan sulfate-related glycosaminoglycan promotes the generation of functional regulatory T cells.
Martín-Cruz L, Viñuela M, Kalograiaki I, Angelina A, Oquist-Phillips P, Real-Arévalo I, Cañada FJ, Tudela JI, Moltó L, Moreno-Sierra J, Subiza JL, Palomares O. Martín-Cruz L, et al. Among authors: palomares o. Cell Mol Immunol. 2023 Dec;20(12):1499-1512. doi: 10.1038/s41423-023-01096-9. Epub 2023 Nov 22. Cell Mol Immunol. 2023. PMID: 37990034 Free PMC article.
EPI-SURVEY. Grade of awareness of Spanish allergist, hospital pharmacist, and pulmonologists on the relevance of bronchial epithelium and alarmins in the pathogenesis and management of severe asthma.
Plaza V, Eguíluz I, Garin N, Martínez Moragón E, Palomares O, Dávila I. Plaza V, et al. Among authors: palomares o. J Investig Allergol Clin Immunol. 2024 Feb 14:0. doi: 10.18176/jiaci.0997. Online ahead of print. J Investig Allergol Clin Immunol. 2024. PMID: 38353099 Free article. No abstract available.
Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology.
Roth-Walter F, Adcock IM, Benito-Villalvilla C, Bianchini R, Bjermer L, Caramori G, Cari L, Chung KF, Diamant Z, Eguiluz-Gracia I, Knol EF, Jesenak M, Levi-Schaffer F, Nocentini G, O'Mahony L, Palomares O, Redegeld F, Sokolowska M, Van Esch BCAM, Stellato C. Roth-Walter F, et al. Among authors: palomares o. Allergy. 2024 May;79(5):1089-1122. doi: 10.1111/all.15977. Epub 2023 Dec 18. Allergy. 2024. PMID: 38108546 Review.
Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper.
Jutel M, Agache I, Zemelka-Wiacek M, Akdis M, Chivato T, Del Giacco S, Gajdanowicz P, Gracia IE, Klimek L, Lauerma A, Ollert M, O'Mahony L, Schwarze J, Shamji MH, Skypala I, Palomares O, Pfaar O, Torres MJ, Bernstein JA, Cruz AA, Durham SR, Galli SJ, Gómez RM, Guttman-Yassky E, Haahtela T, Holgate ST, Izuhara K, Kabashima K, Larenas-Linnemann DE, von Mutius E, Nadeau KC, Pawankar R, Platts-Mills TAE, Sicherer SH, Park HS, Vieths S, Wong G, Zhang L, Bilò MB, Akdis CA. Jutel M, et al. Among authors: palomares o. Allergy. 2023 Nov;78(11):2851-2874. doi: 10.1111/all.15889. Epub 2023 Oct 10. Allergy. 2023. PMID: 37814905
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs.
Kolkhir P, Akdis CA, Akdis M, Bachert C, Bieber T, Canonica GW, Guttman-Yassky E, Metz M, Mullol J, Palomares O, Renz H, Ständer S, Zuberbier T, Maurer M. Kolkhir P, et al. Among authors: palomares o. Nat Rev Drug Discov. 2023 Sep;22(9):743-767. doi: 10.1038/s41573-023-00750-1. Epub 2023 Aug 1. Nat Rev Drug Discov. 2023. PMID: 37528191 Review.
Could we co-opt the cannabinoid system for asthma therapy?
Palomares O. Palomares O. Expert Rev Clin Immunol. 2023 Jul-Dec;19(10):1183-1186. doi: 10.1080/1744666X.2023.2235082. Epub 2023 Jul 10. Expert Rev Clin Immunol. 2023. PMID: 37420178 No abstract available.
144 results